Motac Neuroscience

Motac Neuroscience is a private UK-based neuroscience-focused preclinical contract research company supporting pharmaceutical and biotechnology clients developing therapies for central nervous system disorders. The company specializes in proof-of-concept and efficacy studies, with particular depth in Parkinson's disease, movement disorders, cognition, and broader neurological and psychiatric disease models. Its service offering spans in vivo and ex vivo pharmacology, stereotactic surgery, neurohistology, neurochemistry, cognitive and behavioral testing, and chronic calcium imaging, using rodent and non-human primate models. In addition to fee-for-service CRO work, Motac states that it holds intellectual property around new chemical entities and therapeutic targets for movement disorders and develops some assets through strategic alliances and partnerships. The company also participates in collaborative research projects in areas such as Parkinson's disease RNA therapeutics and vaccine-enabled diagnostics.